Skip to main content
. 2014 Dec 2;30(3):334–341. doi: 10.1007/s11606-014-3113-5

Table 3.

Physician Counseling About Test Result Implications for the SP, Sorted by Combined Frequency of Occurrence*

Topic Control
(n = 61)
Intervention
(n = 60)
Combined
(n = 121)
P
Cancer risks
 Positive result means increased risk of breast cancer 45 (73.8 %) 43 (71.7 %) 88 (72.3 %) 0.84
 Positive result means increased risk of ovarian cancer 38 (62.3 %) 32 (53.3 %) 70 (57.9 %) 0.36
Treatment implications
 Positive result introduces option of surgical treatment 57 (93.4 %) 55 (91.7 %) 112 (92.6 %) 0.74
 Positive result has fertility implications due to effects of prophylactic treatments (oophorectomy) 13 (21.3 %) 19 (31.7 %) 32 (26.5 %) 0.22
 Positive result introduces option of prophylaxis with medications 19 (31.2 %) 11 (18.3 %) 30 (24.8 %) 0.14
Screening implications
 Positive result means more ongoing testing/screening 49 (80.3 %) 52 (86.7 %) 101 (83.5 %) 0.46
 Positive result underscores the importance of self-monitoring with breast exams 6 (9.8 %) 5 (8.3 %) 11 (9.1 %) 1.0
Test limitations
 Even with negative result, SP (and/or sister) could still get breast cancer 21 (34.4 %) 17 (28.3 %) 38 (31.4 %) 0.56
 Tests only look for known mutations 15 (24.6 %) 17 (28.3 %) 32 (26.5 %) 0.68
 Genetic testing is not 100 % accurate 8 (13.1 %) 4 (6.7 %) 12 (9.9 %) 0.36
Emotional issues
 Physician discusses emotional repercussions of testing for SP 27 (44.3 %) 30 (50.0 %) 57 (47.1 %) 0.59
 Physician discusses how a negative test result could be beneficial to the SP (e.g., reassurance) 23 (37.7 %) 19 (31.7 %) 42 (34.7 %) 0.57
 Physician asks if SP has support system (in relation to BRCA testing) 2 (3.3 %) 3 (5.0 %) 5 (4.1 %) 0.68

*Values reported are the numbers (percentages) of physicians who raised the topic during the visit.

† Probability values are based on Fisher’s exact test.